(Q43581194)

24 November 2017

A feature based pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors (English)

1 reference

24 November 2017

1 reference

Karki RG

1

1 reference

PubMed ID

11311746

24 November 2017

Kulkarni VM

series ordinal

2

1 reference

24 November 2017

1 February 2001

1 reference

European Journal of Medicinal Chemistry

24 November 2017

1 reference

24 November 2017

36

1 reference

24 November 2017

2

1 reference

24 November 2017

147-163

1 reference

Genetic and biochemical studies of protein N-myristoylation

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

1 reference

7 January 2021

Understanding covalent modifications of proteins by lipids: where cell biology and biophysics mingle.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Disruption of the yeast N-myristoyl transferase gene causes recessive lethality.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Genetic studies reveal that myristoylCoA:protein N-myristoyltransferase is an essential enzyme in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Scanning alanine mutagenesis and de-peptidization of a Candida albicans myristoyl-CoA:protein N-myristoyltransferase octapeptide substrate reveals three elements critical for molecular recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Pharmacophores incorporating numerous excluded volumes defined by X-ray crystallographic structure in three-dimensional database searching: application to the thyroid hormone receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

A QSAR study of the antimalarial activity of some synthetic 1,2,4-trioxanes.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Pharmacophore development for corticotropin-releasing hormone: new insights into inhibitor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifung

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Comparative molecular field analysis of fungal squalene epoxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Crystal structure of the anti-fungal target N-myristoyl transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2800%2901202-2

7 January 2021

10.1016/S0223-5234(00)01202-2

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11311746